Literature DB >> 22006026

Oversizing and restenosis with self-expanding stents in iliofemoral arteries.

Ardan M Saguner1, Tobias Traupe, Lorenz Räber, Nina Hess, Yara Banz, Arhan R Saguner, Nicolas Diehm, Otto M Hess.   

Abstract

PURPOSE: Uncoated self-expanding nitinol stents (NS) are commonly oversized in peripheral arteries. In current practice, 1-mm oversizing is recommended. Yet, oversizing of NS may be associated with increased restenosis. To provide further evidence, NS were implanted in porcine iliofemoral arteries with a stent-to-artery-ratio between 1.0 and 2.3. Besides conventional uncoated NS, a novel self-expanding NS with an antiproliferative titanium-nitride-oxide (TiNOX) coating was tested for safety and efficacy.
METHODS: Ten uncoated NS and six TiNOX-coated NS (5-6 mm) were implanted randomly in the iliofemoral artery of six mini-pigs. After implantation, quantitative angiography (QA) was performed for calculation of artery and minimal luminal diameter. Follow-up was performed by QA and histomorphometry after 5 months.
RESULTS: Stent migration, stent fracture, or thrombus formation were not observed. All stents were patent at follow-up. Based on the location of the stent (iliac/femoral) and the stent-to-artery-ratio, stent segments were divided into "normal-sized" (stent-to-artery-ratio < 1.4, n = 12) and "oversized" (stent-to-artery-ratio ≥ 1.4, n = 9). All stent segments expanded to their near nominal diameter during follow-up. Normal-sized stent segments increased their diameter by 6% and oversized segments by 29%. A significant correlation between oversizing and restenosis by both angiography and histomorphometry was observed. Restenosis rates were similar for uncoated NS and TiNOX-coated NS.
CONCLUSIONS: TiNOX-coated NS are as safe and effective as uncoated NS in the porcine iliofemoral artery. All stents further expand to near their nominal diameter during follow-up. Oversizing is linearly and positively correlated with neointimal proliferation and restenosis, which may not be reduced by TiNOX-coating.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006026     DOI: 10.1007/s00270-011-0275-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  5 in total

1.  Lesion Revascularisation Subsequent to Femoropopliteal Spot Stenting Using the Multi-LOC Stent Delivery System.

Authors:  Martin Sigl; Klaus Amendt; Matthias Waliszewski; Nils Rathmann
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

2.  Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.

Authors:  Alexander Wressnegger; Alexandra Kaider; Martin A Funovics
Journal:  Trials       Date:  2017-12-14       Impact factor: 2.279

3.  Endovascular repair of traumatic axillosubclavian artery injuries.

Authors:  Jason Zhang; Rohan Basu; Andrew R Bauder; Jon G Quatramoni; Julia Glaser; Venkat Kalapatapu; Ann C Gaffey
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-12-08

4.  [Efficacy and Safety of a Newly Developed Self-Expanding Open-Cell Type Nitinol Stent for Peripheral Arteries: A Preclinical Study in Minipigs].

Authors:  Min Uk Kim; Jae Hwan Lee; Chang Jin Yoon; Won Seok Choi; Saebeom Hur; Jin Wook Chung
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-07-30

5.  Impact of chronic outward force on arterial responses of proximal and distal of long superficial femoral artery stent.

Authors:  Hu Li; Seung-Woon Rha; Byoung Geol Choi; Se Yeon Choi; Sang Ki Moon; Won Young Jang; Woohyeun Kim; Ji Hun Ahn; Sang-Ho Park; Woong Gil Choi; Rui Feng Yang; Wen Wei Bai; Cheol Ung Choi; Yang Gi Ryu; Man Jong Baek; Dong Joo Oh
Journal:  BMC Cardiovasc Disord       Date:  2021-06-30       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.